Plante Moran Financial Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $210K | Hold |
635
| – | – | 0.01% | 156 |
|
|
2025
Q4 | $253K | Sell |
635
-2
| -0.3% | -$885 | 0.02% | 152 |
|
|
2025
Q3 | $290K | Sell |
637
-648
| -50% | -$264K | 0.02% | 132 |
|
|
2025
Q2 | $419K | Hold |
1,285
| – | – | 0.03% | 96 |
|
|
2025
Q1 | $347K | Buy |
1,285
+650
| +102% | +$167K | 0.03% | 112 |
|
|
2024
Q4 | $149K | Hold |
635
| – | – | 0.01% | 208 |
|
|
2024
Q3 | $175K | Sell |
635
-465
| -42% | -$121K | 0.01% | 197 |
|
|
2024
Q2 | $267K | Hold |
1,100
| – | – | 0.03% | 142 |
|
|
2024
Q1 | $164K | Hold |
1,100
| – | – | 0.02% | 186 |
|
|
2023
Q4 | $211K | Buy |
+1,100
| New | +$187K | 0.02% | 161 |
|
|
2020
Q4 | – | Sell |
-100
| Closed | -$15K | – | 877 |
|
|
2020
Q3 | $15K | Buy |
+100
| New | +$14.2K | 0.01% | 542 |
|
|
2018
Q3 | – | Sell |
-16
| Closed | -$2K | – | 752 |
|
|
2018
Q2 | $2K | Sell |
16
-11
| -41% | -$1.09K | ﹤0.01% | 708 |
|
|
2018
Q1 | $3K | Buy |
27
+15
| +125% | +$1.93K | ﹤0.01% | 774 |
|
|
2017
Q4 | $2K | Sell |
12
-2
| -14% | -$251 | ﹤0.01% | 779 |
|
|
2017
Q3 | $2K | Buy |
+14
| New | +$1.2K | ﹤0.01% | 713 |
|
|
2017
Q2 | – | Sell |
-12
| Closed | -$1K | – | 827 |
|
|
2017
Q1 | $1K | Sell |
12
-42
| -78% | -$1.94K | ﹤0.01% | 813 |
|
|
2016
Q4 | $2K | Hold |
54
| – | – | ﹤0.01% | 841 |
|
|
2016
Q3 | $4K | Sell |
54
-6
| -10% | -$423 | ﹤0.01% | 725 |
|
|
2016
Q2 | $3K | Hold |
60
| – | – | ﹤0.01% | 702 |
|
|
2016
Q1 | $4K | Buy |
+60
| New | +$3.99K | ﹤0.01% | 604 |
|
Other funds holding ALNY
VPM
VCM
